COST-EFFECTIVENESS ANALYSIS OF DAPTOMYCIN VERSUS VANCOMYCIN IN COMPLICATED SKIN AND SOFT STRUCTURE INFECTION (CSSSI) USING A DECISION ANALYTIC MODEL

被引:0
|
作者
Zargarzadeh, A. [1 ]
Bounthavong, M. [2 ]
Hsu, D. [1 ]
Okamoto, M. P. [3 ]
机构
[1] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA
[2] VASDHS, San Diego, CA USA
[3] Univ Hawaii, Coll Pharm, Hilo, HI 96720 USA
关键词
D O I
10.1016/S1098-3015(10)73620-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A111 / A112
页数:2
相关论文
共 50 条
  • [31] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    Ramos, G. Feljandro P.
    van Asselt, Antoinette D. I.
    Kuiper, Sandra
    Severens, Johan L.
    Maas, Tanja
    Dompeling, Edward
    Knottnerus, J. Andre
    van Schayck, Onno C. P.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (08): : 869 - 883
  • [32] Fitting nutrition into the medical model: the role of decision analytic cost-effectiveness techniques
    EM Ross
    IH Rosenberg
    B Dawson-Hughes
    NF Col
    JB Wong
    European Journal of Clinical Nutrition, 1999, 53 : s25 - s28
  • [33] COST-EFFECTIVENESS OF MATERNAL TOXOPLASMA SCREENING IN AUSTRIA: A DECISION-ANALYTIC MODEL
    Prusa, A. R.
    Walter, E.
    Pollak, A.
    Hayde, M.
    Kasper, D. C.
    VALUE IN HEALTH, 2013, 16 (07) : A333 - A333
  • [34] Fitting nutrition into the medical model: the role of decision analytic cost-effectiveness techniques
    Ross, EM
    Rosenberg, IH
    Dawson-Hughes, B
    Col, NF
    Wong, JB
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1999, 53 (Suppl 2) : S25 - S28
  • [35] Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States
    Stranges, Paul M.
    Hutton, David W.
    Collins, Curtis D.
    VALUE IN HEALTH, 2013, 16 (02) : 297 - 304
  • [36] COST-EFFECTIVENESS STUDY OF THE USE OF DAPTOMYCIN VERSUS VANCOMYCIN IN INFECTIVE ENDOCARDITIS AND BACTEREMIA TREATMENT IN PUBLIC HEALTH INSTITUTIONS IN MEXICO
    Soria-Cedillo, I. F.
    Baca-Muro, V., I
    De la Mora-Chavez, T.
    Jirash, J.
    Garcia-Contreras, F.
    VALUE IN HEALTH, 2009, 12 (07) : A427 - A427
  • [37] Cost-effectiveness of unicondylar versus total model analysis
    Peersman, Geert
    Vandenlangenbergh, Tom
    Jans, Christophe
    Cartier, Philippe
    Fennema, Peter
    KNEE, 2014, 21 : S37 - S42
  • [38] Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid
    Wright, Bradley M.
    Eiland, Edward H., III
    JOURNAL OF PATHOGENS, 2011, 2011
  • [39] LINEZOLID FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) - A COST-EFFECTIVENESS ANALYSIS FOR THE CHILEAN NATIONAL FUND OF HEALTH
    Mould-Quevedo, J. F.
    Vargas Zea, N.
    Diaz-Sotelo, O. D.
    Villamil Munevar, V.
    Ortiz, Vecino A.
    VALUE IN HEALTH, 2013, 16 (03) : A88 - A89
  • [40] Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques
    Mark J.C. Nuijten
    Frans Rutten
    PharmacoEconomics, 2002, 20 : 855 - 867